Future organ shortage crises may persist despite advances in regenerative medicine.

open Global / Unspecified, Global WS02064

Bioprinting and stem-cell therapies may not scale fast enough to meet demand. Organ-allocation optimisation and cross-border sharing platforms remain important.

health-biology global-unspecified may future organ shortage crises persist despite advances regenerative medicine climate-environment technology-computing food whether philosophy-ethics microbial

Category: Health Biology

Added by: Ian Patel

Created at: 2026-07-22T20:40:00Z

Horizon: 10-20 years

Click to copy citation

WS02064 | World Solve | https://www.worldsolve.org/index.php?view=problem&id=2064

Related Problems

We haven't solved how to make organ transplants available to more patients without relying solely on donor scarcity.

WS00528 · Match Score: 20%

New cancer therapies will demand better real-world data to understand long-term outcomes.

WS02048 · Match Score: 20%

New cancer therapies will demand better real-world data to understand long-term outcomes. This variant focuses on data infrastructure and measurement challenges over the next two decades.

WS02049 · Match Score: 18%

We can't grow replacement organs that a patient's body won't reject.

WS00060 · Match Score: 17%

We haven't found a way to make organ donation opt-out, not opt-in, fairly and globally.

WS00226 · Match Score: 15%